Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid pulse therapy for advanced tertiary lymphoid tissues after living-donor kidney transplantation
jRCT1051260147Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylprednisolone in kidney allograft rejection and renal allograft fibrosis (IF/TA) (2 arms), sponsored by Japan Agency for Medical Research and Development. Started Aug 2026; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
kidney allograft rejectionrenal allograft fibrosis (IF/TA)
Beyond the preview
Go deeper on jRCT1051260147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260147.